Filed: 5/15/2025ACC: 0000904454-25-000276
📋 What this filing means
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $631.50M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$631.50M
Total AUM (reported)
3.13M
Total Shares
Allocation by class
TR UNIT$620.56M98.3%
ORD SHS CL A$9.32M1.5%
COM$1.63M0.3%
*W EXP 08/01/2$1.0K0.0%
Portfolio Concentration
Top 3$630.43M99.8%
4–10$1.07M0.2%
Top 3 weight
99.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 3.13M
Sole
Full voting authority
3.13M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
SPDR S&P 500 ETF TR
SOLEShares1.11M
TypeSH
Market value$620.56M
98.27%
Sole
1.11M
Shared
0.00
None
0.00
NU HLDGS LTD
SOLEShares909.93K
TypeSH
Market value$9.32M
1.48%
Sole
909.93K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares47.93K
TypeSH
Market value$558.9K
0.09%
Sole
47.93K
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares192.97K
TypeSH
Market value$343.5K
0.05%
Sole
192.97K
Shared
0.00
None
0.00
Q32 BIO INC
SOLEShares133.90K
TypeSH
Market value$220.9K
0.03%
Sole
133.90K
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares249.63K
TypeSH
Market value$180.7K
0.03%
Sole
249.63K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares291.83K
TypeSH
Market value$166.3K
0.03%
Sole
291.83K
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares73.38K
TypeSH
Market value$89.5K
0.01%
Sole
73.38K
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares91.91K
TypeSH
Market value$66.0K
0.01%
Sole
91.91K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares33.33K
TypeSH
Market value$1.0K
<0.01%
Sole
33.33K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 1.11M | SH | $620.56M 98.27% | 1.11M | 0.00 | 0.00 |
NU HLDGS LTDSOLE | ORD SHS CL A | 909.93K | SH | $9.32M 1.48% | 909.93K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM | 47.93K | SH | $558.9K 0.09% | 47.93K | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 192.97K | SH | $343.5K 0.05% | 192.97K | 0.00 | 0.00 |
Q32 BIO INCSOLE | COM | 133.90K | SH | $220.9K 0.03% | 133.90K | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 249.63K | SH | $180.7K 0.03% | 249.63K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 291.83K | SH | $166.3K 0.03% | 291.83K | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 73.38K | SH | $89.5K 0.01% | 73.38K | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM | 91.91K | SH | $66.0K 0.01% | 91.91K | 0.00 | 0.00 |
SURROZEN INCSOLE | *W EXP 08/01/2 | 33.33K | SH | $1.0K <0.01% | 33.33K | 0.00 | 0.00 |